Published Date: 13 Mar 2023
Hemophilia A is a rare bleeding disorder caused by a genetically encoded factor VIII mutation that affects blood clotting. sick...
Read Full NewsHome visits — once common and now resurging — flip the dynamic, as the clinician becomes a guest in the patient's home. Experts say as both learn more about each other than is possible in-office, trust can build.
Higher body fat percentage, rather than BMI, is associated with reduced sperm count and disrupted reproductive hormone levels in men.
Standard TKI doses are often too high for long-term care. Dr Mark Kris shares his strategy for smart dose reductions that protect patient outcomes.
Cure rates are climbing, and so is the complexity of getting there. Dr Yara Abdou takes a closer look at optimizing HER2+ early-stage breast cancer therapy.
Direct primary care is more than medicine. Dr Rajdeep Dhami shares what physicians should know before starting DPC, from operations and branding to boundaries and community.
1.
How to keep your prostate healthy and lower your risk of developing serious problems
2.
Top 10 questions about breast cancer answered
3.
Only 1 in 4 Eligible Adults Receive Lung Screening
4.
Researchers found that patients undergoing chemotherapy had a higher risk of mixed infections and should begin antibiotic therapy right away.
5.
The Truth About Apple AirPods
1.
Radiomics-Based Prediction of Treatment Response in Cancer
2.
Contemporary Models in Oncology for Healthcare Excellence
3.
A Mural of Thrombus: Unlocking the Power of Art to Combat Cardiovascular Disease
4.
Tremelimumab: A Potential Breakthrough in Cancer Treatment
5.
Breaking Barriers: Innovative Approaches in Brain Tumor Treatment
1.
Asian Symposium on Advancement in Hematology and Oncology
2.
Asian Symposium on Advancement in Hematology and Oncology
3.
Asian Symposium on Advancement in Hematology and Oncology
4.
International Cancer Conference
5.
Asian Symposium on Advancement in Hematology and Oncology
1.
Pazopanib: A Game-Changer in Managing Advanced Renal Cell Carcinoma
2.
From Relapse to Remission: Mapping the Treatment Journey in Adult R/R-Cell ALL - Part 2
3.
Dissecting Molecular differences between EGFR Exon 19 deletion and Exon 21 L858R Mutations
4.
Untangling The Best Treatment Approaches For ALK Positive Lung Cancer - Part I
5.
A Continuation to Deep Dive Into EGFR Mutation Positive Non-Small Cell Lung Cancer
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation